Antibacterial activity and mechanism of naphthoquine phosphate against ceftazidime-resistant Acinetobacter baumannii via cell membrane disruption and ROS induction

QR Code

Antibacterial activity and mechanism of naphthoquine phosphate against ceftazidime-resistant Acinetobacter baumannii via cell membrane disruption and ROS induction

IntroductionDrug-resistant bacteria, particularly Acinetobacter baumannii, present a significant threat to global public health, highlighting the urgent need for novel antibacterial therapies. Drug repurposing has emerged as a promising strategy to accelerate therapeutic development by identifying n...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yongtian Yuan, Liangliang Zhao, Zhuchun Bei, Baogang Wang, Dongna Zhang, Likun Xu, Jiahui Liu, Meng Lv, Qin Xu, Yabin Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Microbiology
Subjects:	naphthoquine phosphate Acinetobacter baumannii antibacterial activity cell membrane permeability transcriptome analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1603462/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pathogenicity factors of Acinetobacter baumannii
by: E. N. Gudueva, et al.
Published: (2023-03-01)

Genotypes and β-Lactamase Gene Carriage in Carbapenem-Resistant Acinetobacter Baumannii Isolated in Moscow
by: I. V. Chebotar, et al.
Published: (2020-05-01)

Influence of Cold Atmospheric Plasma on Acinetobacter baumannii
by: Atta et al.
Published: (2019-03-01)

Antibiotic Activity of Probiotic Strain Bacillus subtilis 534 Against Clinical Isolates of Acinetobacter baumannii
by: O. V. Efremenkova, et al.
Published: (2020-05-01)

Evaluation of Some Material to inhibit Biofilm Formed by Acinetobacter baumannii Isolates
by: Noor Hussein Ahmad, et al.
Published: (2019-08-01)

Colistin as A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter baumannii In vivo and In vitro
by: Halah H. Al-Haideri, et al.
Published: (2022-04-01)

Identification of Acinetobacter baumannii and Determination of MDR and XDR Strains
by: Noor Hussein Ahmad, et al.
Published: (2020-07-01)

Prevalence of carbapenem resistance genes in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii from meat samples
by: Maryam Rezaeian, et al.
Published: (2025-01-01)

Study the Role of the Efflux Pump in Multidrug-Resistant Acinetobacter baumannii
by: Nazhad Hassan Mohammed, et al.
Published: (2023-04-01)

Carnosol attenuates Acinetobacter baumannii virulence by interfering with indole-mediated quorum sensing
by: Binbin Cui, et al.
Published: (2025-12-01)

Hypervirulent <i>Acinetobacter baumannii</i> (hvAB): The Convergence of Virulence and Multidrug Resistance
by: Nan Wu, et al.
Published: (2025-05-01)

ANTIBIOTIC RESISTANCE OF ACINETOBACTER BAUMANNII AT CAN THO GENERAL HOSPITAL IN 2019–2023
by: Thi Ngoc Nga Pham, et al.
Published: (2025-06-01)

Imazamox microbial degradation by common clinical bacteria: Acinetobacter baumannii IB5 isolated from black soil in China shows high potency
by: Chun-guang LIU, et al.
Published: (2016-08-01)

Exploring the additive antibacterial potential of Cinnamomum cassia volatile oil and imipenem against Acinetobacter baumannii: a multi-omics investigation
by: Youyuan Lu, et al.
Published: (2025-07-01)

Genomic insights into biofilm-associated virulence in extensively drug-resistant Acinetobacter baumannii
by: Made Rai Dwitya Wiradiputra, et al.
Published: (2025-01-01)

Venovenous extracorporeal membrane oxygenation in severe community-acquired Acinetobacter baumannii pneumonia
by: Lei Jiang, et al.
Published: (2025-06-01)

Expresión fenotípica de resistencia de Acinetobacter baumannii aislado en pacientes de servicios de medicina crítica durante 2017 y 2018
by: Noel de J. Díaz-Robles, et al.
Published: (2023-04-01)

Correlation Between the Distribution of Virulence Genes and Drug Resistance Genes and Clinical Characteristics of Lower Respiratory Tract Infections with Acinetobacter baumannii and Klebsiella pneumoniae
by: Yang J, et al.
Published: (2025-06-01)

mRNA-LNP Vaccines Targeting SmpA-PLD and OmpK-Omp22 Induce Protective Immunity Against <i>Acinetobacter baumannii</i>
by: Cong Liu, et al.
Published: (2025-07-01)

Synergy of ATP and Meropenem in Stimulating the TCA Cycle to Enhance Killing of Carbapenem‐Resistant Acinetobacter baumannii
by: Xia Li, et al.
Published: (2025-07-01)

Phage derived lytic peptides, a secret weapon against Acinetobacter baumannii—An in silico approach
by: Abhishek Nandy, et al.
Published: (2022-11-01)

Correction: Phage derived lytic peptides, a secret weapon against Acinetobacter baumannii—An in silico approach
by: Abhishek Nandy, et al.
Published: (2025-06-01)

The Innovative Method for Vaccine Preparation Against Multidrug Resistant and Virulence Acinetobacter baumannii Iraqi Isolates
by: Baghdad Science Journal
Published: (2017-12-01)

Genomic characterization of multidrug-resistant clinical Acinetobacter baumannii isolates from a hospital in Paraguay
by: Sandra Sánchez-Urtaza, et al.
Published: (2025-07-01)

Insights of Terminalia citrina (Gaertn.) Roxb. Ex Fleming inhibiting multidrug resistant Acinetobacter baumannii
by: Nevia Longjam, et al.
Published: (2025-08-01)

In silico and in vitro comparative analysis of 79 Acinetobacter baumannii clinical isolates
by: Martina Scarrone, et al.
Published: (2025-07-01)

Impact of COVID-19 on epidemiology and mortality risk factors in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections in a tertiary care hospital in Thailand
by: Darunee Chotiprasitsakul, et al.
Published: (2025-06-01)

Epidemiology of Acinetobacter baumannii: analysis of hazard factors associated with positivity cases in Guizhou province, China from 2015 to 2023
by: Zhongzhi Liang, et al.
Published: (2025-07-01)

The Negative Regulatory Role of Transcriptional Regulator H-NS on the Type VI Secretion System in Acinetobacter baumannii
by: Zhang Y, et al.
Published: (2025-06-01)

A matched pilot cohort study of intravenous omadacycline in the treatment of severe pneumonia associated with carbapenem-resistant Acinetobacter baumannii
by: Dayu Chen, et al.
Published: (2025-07-01)

INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII IN CANCER PATIENTS
by: N. V. Dmitrieva, et al.
Published: (2019-06-01)

A Developed Colorimetric Assay Using Unmodified Gold Nanoparticles for the Identification of Acinetobacter baumannii Isolates from Different Clinical Samples
by: Mohamed M. Sehree, et al.
Published: (2023-08-01)

Carbapenem Resistance in <i>Acinetobacter baumannii</i>: Mechanisms, Therapeutics, and Innovations
by: Joyce de Souza, et al.
Published: (2025-06-01)

Evolutionary dynamics and research hotspots of phage applications against Acinetobacter baumannii infections from the past to the new era
by: Ping Jiang, et al.
Published: (2025-06-01)

In silico design of sgRNAs with knockout potential for the adeB gene of the AdeABC efflux pump of Acinetobacter baumannii
by: José Miguel Benigno Delgado Ruitón, et al.
Published: (2025-09-01)

Susceptibility toward cefiderocol and sulbactam-durlobactam in extensively drug-resistant Acinetobacter baumannii detected from ICU admission screening in Hanoi, Vietnam, 2023
by: Sébastien Boutin, et al.
Published: (2025-07-01)

Comparative efficacy of intravenous versus intravenous combined with intrathecal/intracerebral ventricle injection of polymyxin B for Acinetobacter baumannii intracranial infection: A retrospective study
by: Li You, et al.
Published: (2025-09-01)

Pharmacodynamic Evaluation of Adjuvant Targets: Low Molecular Weight PBP7/8 Effects on β-Lactam Activity Against Carbapenem-Resistant Acinetobacter Baumannii
by: Brian M. Ho, et al.
Published: (2025-06-01)

Prevalence of carbapenem non-susceptible multidrug resistant Acinetobacter baumannii in Madinah, Saudi Arabia
by: Abdulmajeed Alqurashi, et al.
Published: (2025-08-01)

Orthopedic infections associated with distinct Acinetobacter strains in rural area of Qingdao, China
by: Ying Wang, et al.
Published: (2025-07-01)